HSP90B1 and nasopharyngeal carcinoma: Our previous work has shown that GP96 contributed to radioresistance in nasopharyngeal carcinoma (NPC) and ORC cell lines [14,15], indicating that this molecule may affect the efficacy of radiotherapy.